Newsletter Archive

COVID-19 News

Sasakawa Grant Program

Sasakawa Health Foundation Announces Grant Recipients: Organizations of Persons Affected by Leprosy During COVID-19

4 November, 2020 | Sasakawa Health Foundation

TOKYO, Oct. 29, 2020 — Sasakawa Leprosy (Hansen’s Disease) Initiative will launch a US$340,000 grant program on November 1 to support communities of persons affected by leprosy around the world that have been hard hit by the effects of the … More Sasakawa Health Foundation Announces Grant Recipients: Organizations of Persons Affected by Leprosy During COVID-19

Read Article >
Sasakawa Health Foundation Nepal

Grant Program for Organizations of Persons Affected by Leprosy/Hansen’s Disease During the COVID-19 Pandemic

24 September, 2020 | Sasakawa Health Foundation

Sasakawa Health Foundation with support from The Nippon Foundation is implementing a grant program for organizations of persons affected by leprosy/Hansen’s disease to support people who have been severely impacted by the unprecedented crisis caused by the spread of the … More Grant Program for Organizations of Persons Affected by Leprosy/Hansen’s Disease During the COVID-19 Pandemic

Read Article >
Nepali woman receives skin exam

The COVID-19 Crisis and Persons Affected by Leprosy: Questionnaire Results

9 September, 2020 | Global Partnership for Zero Leprosy

The economic, social, and health impacts of the COVID-19 pandemic have led to a significant increase in the need for humanitarian aid and social protection measures. Persons affected by leprosy have been especially impacted by the worst consequences of the pandemic, due to preexisting vulnerabilities and economic precarity.

Governments, NGOs, civil society organizations, and organizations of persons affected by leprosy have enacted policies and programmes intended to support persons affected during this crisis, although there are still gaps. To support the effectiveness of these interventions, and to help raise awareness of resources available to persons affected, the Global Partnership for Zero Leprosy’s COVID-19 Emergency Advocacy Working Group and UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members Alice Cruz, gathered data on available programmes and resources. The following information was gathered through an online questionnaire from 100+ persons affected and partners, representing 24 countries.

Read Article >
Working with Programs

GPZL’s COVID-19 Working Groups: August 2020 Update

11 August, 2020 | Global Partnership for Zero Leprosy

The COVID-19 pandemic has strongly impacted leprosy control and prevention, and in response, GPZL has established three working groups to address the leprosy community’s key challenges during the global health crisis, and spearhead emergency response. This article is an update on their progress.

Read Article >
Novartis Multi-drug therapy manufacturing

Novartis Kalwe Site Associates Live On-Site during COVID-19 Lockdown to Maintain Multi-Drug Therapy Supply Chain for WHO Donation Program

6 August, 2020 | Global Partnership for Zero Leprosy

The COVID-19 pandemic has halted many leprosy control and prevention activities globally, putting vulnerable communities further at risk. The Novartis Technical Operations (NTO) Sandoz Kalwe site, located north of Mumbai on India’s west coast, faced new challenges beginning earlier this … More Novartis Kalwe Site Associates Live On-Site during COVID-19 Lockdown to Maintain Multi-Drug Therapy Supply Chain for WHO Donation Program

Read Article >
Working with Programs

GPZL’s COVID-19 Working Groups: June 2020 Update

16 June, 2020 | Global Partnership for Zero Leprosy

The COVID-19 pandemic has strongly impacted leprosy control and prevention, and in response, GPZL has established three working groups to address the leprosy community’s key challenges during the global health crisis, and spearhead emergency response. This article is an update on their progress.

Read Article >
Working with Programs

GPZL’s COVID-19 Working Groups: May 2020 Update

12 May, 2020 | Global Partnership for Zero Leprosy

The COVID-19 pandemic has strongly impacted leprosy control and prevention, and in response, GPZL has established three working groups to address the leprosy community’s key challenges during the global health crisis, and spearhead emergency response. This article is an update on their progress.

Read Article >
Multi-drug therapy

GPZL’s COVID-19 Emergency Response Plan for 2020

14 April, 2020 | Global Partnership for Zero Leprosy

With the COVID-19 pandemic raging in some countries and just beginning to be felt in others, GPZL’s Leadership Team has identified the leprosy community’s key challenges and outlined an emergency response plan for 2020. This plan will ensure that the GPZL’s substantial expertise and network is focused on the urgent situation being faced by National Leprosy Programmes and persons affected by the disease, and their families.

Read Article >